KENNEDY SPACE CENTER — Strong winds and ominous clouds forced SpaceX to scrub its Falcon Heavy rocket launch of the ViaSat company’s telecommunications satellite on Monday morning. The rarely seen ...
A new report from The Information shares fresh details on how the new Gemini-powered Siri will work under the hood. Here are the details. Apple doubles down on privacy assurances amid AI partnerships ...
New research suggests that AI can compromise cognitive function and problem-solving abilities in as little as ten minutes. While the long-term effects of AI have yet to be established, a new study ...
A Florida deputy dismissed the citation months later due to "lack of evidence" Getty Florida influencer Katie went viral after receiving a distracted driving citation for using her right hand to hold ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. UC Berkeley Law has adopted a new policy banning students' use of AI for academic work they ...
The launch of a new version of SpaceX's mammoth Starship rocket, featuring multiple upgrades, more powerful engines and major safety enhancements was scrubbed at the last minute Thursday by what ...
Add Yahoo as a preferred source to see more of our stories on Google. Stay-at-home mom Catrina shares shock at learning what the 'heavy' setting on her washer means. One stay-at-home mom shared her ...
Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...
Please provide your email address to receive an email when new articles are posted on . Adults receiving semaglutide had a greater decrease in heavy drinking days and alcohol consumption at 26 weeks ...
A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy drinking days in the past 30 days by an average of roughly 12 days, 50% ...
A 26-week, randomized, double-blind trial in Copenhagen enrolled adults 18–70 years with AUD, BMI ≥30 kg/m², ≥6 heavy-drinking days, and AUDIT >15, assigning semaglutide vs placebo 1:1. Compared with ...